A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease - Concepedia

Concepedia

Publication | Open Access

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease

DOI Full Paper Access

134

Citations

20

References

2013

Year

Satish Keshav, Tomáš Vaňásek, Yaron Niv, Robert Petryka, S Howaldt, Mauro Bafutto, I Rácz, David J. Hetzel, Ole Haagen Nielsen, Séverine Vermeire,

Abstract

ClinicalTrials.gov NCT00306215.

References

	Year	Citations

Page 1